IMW 2019 | Updated FDA MRD guidelines for hematological malignancies

Name: Updated FDA MRD guidelines for hematological malignancies
Uploaded: 2019-09-13T00:00:00.000Z
Duration: 2 min 3 s
Description: Nicole Gormley, MD, FDA, Silver Spring, MD, discusses the updated measurable residual disease (MRD) guidlines being produced by the FDA at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Nicole Gormley • 13 Sep 2019

IMW 2019

General

Nicole Gormley, MD, FDA, Silver Spring, MD, discusses the updated measurable residual disease (MRD) guidlines being produced by the FDA at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.